Clinical trial considerations: Why supporting HCPs matters…
February 20, 2024 | Clinical trial support, HCP support, Healthcare professionals, clinical trials, patient support, patients
When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.
Clinical trials are essential for the development of new treatments that can transform patient’s lives. So far, in our Clinical Trial Considerations series, we have focused on how to best support patients throughout the process and on ways to improve their experience. And while it is true that patients have a large part to play in trials, it is important not to overlook the crucial role of healthcare professionals (HCPs) in ensuring the success of clinical research. So how can we help to support HCPs, too?
HCPs play a key role in identifying and recruiting eligible patients, as well as guiding them through the informed consent process and ensuring participants fully understand the potential risks and benefits of taking part. We shouldn’t underestimate how challenging a task this can be, especially when the clinical study protocols provided are often 300+ pages. Throughout the trial, HCPs are also responsible for monitoring patient health and managing any adverse events. Keeping track of symptoms, offering advice to help control them, and realising when more serious intervention may be required is vital for patient safety. No easy feat.
Which is why information in a digestible format is so important for everyone involved.
For example, providing timely and relevant information really can enhance a HCP’s ability to communicate it effectively. When HCPs are equipped with the information they need to aid their own understanding, they find it easier to convey it to patients using simplified language and maintaining a confident and calm tone.
Which is why we design specialised discussion aids for HCPs to use when communicating with patients. And just like clinical trial materials for patients, employing health literacy principles and using imagery where possible in HCP materials also helps to draw out key information and keep the content concise. Which is also why effective HCP materials not only improve the patient experience but also enhance patient recruitment and retention, key success indicators for HCPs conducting clinical studies.
So, whether it’s recruitment aids that quickly inform who may be eligible for a trial, or toxicity management guides that highlight potential adverse events and how to manage them, providing HCPs with support, and in varying formats, at each stage of the clinical trial process is key to future study success.
If you’d like to find out more about the support we can offer HCPs, and how it could support your next trial, let’s talk.
You can read all our latest clinical trials explained blogs here.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Permission to pause: making treatment breaks part of the cancer care conversation
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
A seat at the table: what the EU HTA reforms really ask of patient involvement
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
Why faster trials make participant understanding more important than ever
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
It’s time to stop calling adverse events ‘manageable’
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
The value: why localisation pays off across global trials
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
The solution: Good localisation doesn’t feel translated
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Healthcare information is becoming easier to access. Trust isn’t.
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.